...
首页> 外文期刊>European journal of clinical microbiology and infectious diseases: Official publication of the European Society of Clinical Microbiology >Risk factors and secondary care utilisation in a primary care population with non-tuberculous mycobacterial disease in the UK
【24h】

Risk factors and secondary care utilisation in a primary care population with non-tuberculous mycobacterial disease in the UK

机译:英国非结核性分枝疾病的初级护理人群中的危险因素及二级护理利用

获取原文
获取原文并翻译 | 示例
           

摘要

Prior research has identified risk factors associated with developing non-tuberculous mycobacterial disease (NTMD); we identified risk factors and secondary care utilisation of NTMD patients in the UK. This was a matched case-control study using electronic healthcare records from Clinical Practice Research Datalink from 2006 to 2016. NTMD was defined using prescription data and Read codes, based on international guidelines. Risk factors for NTMD were investigated using conditional logistic regression within a representative general population. All-cause secondary care utilisation (combined inpatient, outpatient, emergency visits) was investigated for participants with linked Hospital Episode Statistics (HES), using incidence rate ratio (IRR) from 2007 to 2015. We identified 1225 individuals with NTMD. A subset of individuals (426 patients) were eligible for linkage with HES. In the adjusted model, risk factors most strongly associated with an increased likelihood of NTMD included previous tuberculosis (OR 69.0; 47.7-99.8); bronchiectasis (OR 23.3; 12.4-43.9); lung cancer (OR 14.9; 3.98-55.7); oral corticosteroids (OCS; OR 7.28; 4.94-10.7); immunosuppressive (excluding corticosteroids) medication (OR 3.05; 1.15-8.10); being underweight (odds ratio (OR) 2.92; 95% CI 1.95, 4.36); and rheumatoid arthritis (OR 2.12; 1.05-4.27). NTMD patients had significantly higher rates of all-cause secondary care utilisation than non-NTMD patients (IRR 5.80; 5.14-6.46). Using a representative adult population, we identified prior TB, bronchiectasis, lung cancer, immunosuppressive medication, and OCS as the risk factors associated with the highest odds of developing NTMD in the UK. Patients with NTMD experienced nearly six times more all-cause secondary care events following their NTMD diagnosis than patients without NTMD.
机译:现有研究确定了与发育非结核病分枝杆菌(NTMD)相关的风险因素;我们确定了英国NTMD患者的危险因素和二级护理利用。这是使用2006年至2016年从临床实践研究数据链接的电子医疗保健记录的匹配案例控制研究。基于国际指南,使用处方数据和读取代码定义了NTMD。在代表普通人口内使用有条件的物流回归研究了NTMD的风险因素。针对2007年至2015年的发病率比(HER),研究了全部导致的二级护理利用(联合住院病人,门诊,紧急访问),为有联系医院统计(HES),从2007年至2015年使用的发病率比(IRR)。我们确定了1225名与NTMD的个人。个人(426名患者)的子集有资格与他联系。在调整后的模型中,与NTMD的可能性增加最强烈相关的风险因素包括先前结核病(或69.0; 47.7-99.8);支气管扩张(或23.3; 12.4-43.9);肺癌(或14.9; 3.98-55.7);口服皮质类固醇(OCS;或7.28; 4.94-10.7);免疫抑制(不包括皮质类固醇)药物(或3.05; 1.15-8.10);体重不足(差距比(或)2.92; 95%CI 1.95,4.36);和类风湿性关节炎(或2.12; 1.05-4.27)。 NTMD患者比非NTMD患者(FRIF 5.80; 5.14-6.46)显着提高全面的二次护理利用率。使用代表性的成年人群,我们确定了先前的TB,支气管扩张,肺癌,免疫抑制药物和OC,作为与英国发展NTMD的最高几率相关的风险因素。患有NTMD的患者在其NTMD诊断之后的近似六倍的次要次要护理事件而不是没有NTMD的患者。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号